Avi Tsur MD

founder and Director of The Sheba Women’s Health Innovation Center

[Avi Tsur MD @avi_tsur]

@perinate1 @MFMSperling @devindirk @FIF780 @AdamUrato1 @icpsupport @ICPcare While Vag P is bioidentical to natural P, 17-OHPC is synthesized by the acetylation of 17-hydroxyprogesterone with caproic acid in the presence of toluene sulfonic acid. Different compounds, different therapeutic effects, different side effects…

[Avi Tsur MD @avi_tsur]

@DanielOramMD @MFMSperling @devindirk @perinate1 @FIF780 @AdamUrato1 @icpsupport @ICPcare P metabolites PM5S & PM4 inhibit bile acid secretion. Prospective studies are powered to detect desired clinical effect (such as preventing sPTB), rather than side effects.

[Avi Tsur MD @avi_tsur]

Congrats @BartalMichal @mfmchauhan @MatthewBicocca and @UTHealthObGyn for validating our shoulder dystocia prediction model (developed with @dvir_a). Now, looking forward for the prospective validation. #MachineLearning #ArtificialIntelligence

[Avi Tsur MD @avi_tsur]

A unique collaboration of ARC innovation at Sheba Medical Center and our department of OBGYN - reaching and serving our patients wherever they are

[Avi Tsur MD @avi_tsur]

Fascinating idea of @orenkolodny and @yoavram

[oren kolodny @orenkolodny]

Pharmaceutical intervention is usually preemptive vaccination or post-infection medication. We suggest a third option. A preprint of our perspective piece on attenuating COVID-19's effects is out; what do you think about this idea?  https://t.co/i1U7k4xu6O  @yoavram #COVID19

[Avi Tsur MD @avi_tsur]

Our study from Stanford:

[SMFM @MySMFM]

Vaginal #progesterone associated with 3-fold increased odds of #cholestasis in this study of 1.7 million pregnancies #SMFM20 https://t.co/oVwg14xWQ6